Author

Hannah Levin

National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Research Focus:fine-mapping· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alexandra M. ThornockiD· 1 shared Andrew WhiteiD· 1 shared Catherine Zhu· 1 shared David Timothy BishopiD· 1 shared Emory HseihiD· 1 shared Erping LongiD· 1 shared Gerard Duncan· 1 shared Goran B JönssoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Alexandra M. ThornockORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased EV yield and bioactivity of matrix-bound nanovesicles compared to conditioned culture medium-derived extracellular vesicles

Andrew White, Catherine Zhu, Vidya Sundaram, Hannah Levin, Marley J. Dewey

This study compares EV yields and bioactivity between liquid-EVs and MBVs from MSCs, finding MBVs have significantly higher yields and are more effective in wound repair.

bioRxiv · Oct 23, 2026 · PreprintBioengineering

Functional characterization of the 9q34.13 locus identifies RAPGEF1 as modulating risk for melanoma and nevi via RAS activation

Rohit Thakur, Mai Xu, Alexandra M. Thornock, Joshuah Yon, Samuel Anyaso-Samuel, Martin Lauss, Thomas Rehling, Linh T. Bui, Hayley Sowards, Gerard Duncan, Lea Jessop, Timothy Myers, Raj Chari, Erping Long, Karen M. Funderburk, , Kevin M. Brown

This study identifies RAPGEF1 as a gene modulating melanoma and nevi risk through RAS activation, using fine-mapping, expression data, and functional assays.

bioRxiv · Feb 9, 2026 · PreprintGenetics